We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRT
301
BRT Apartments
BRT
$282M
| $1.98M | 0.01% |
99,795
-6,700
| -6% | -$124K |
|
302
Petrobras
PBR
$122B
| $1.94M | 0.01% |
140,000
| – | – |
|
|
VMEO
303
DELISTED
Vimeo
VMEO
| $1.93M | 0.01% |
468,051
-1,837
| -0.4% | -$6.96K |
|
|
TXNM
304
TXNM Energy Inc
TXNM
$6.45B
| $1.91M | 0.01% |
42,265
-10,000
| -19% | -$471K |
|
305
DuPont de Nemours
DD
$18.7B
| $1.89M | 0.01% |
21,051
-9,258
| -31% | -$796K |
|
306
BayFirst Financial Corp
BAFN
$31M
| $1.88M | 0.01% |
138,915
+200
| +0.1% | +$2.85K |
|
|
MRSN
307
DELISTED
Mersana Therapeutics
MRSN
| $1.87M | 0.01% |
+22,784
| New | +$3.33M |
|
308
Avantis US Small Cap Value ETF
AVUV
$29.9B
| $1.83M | 0.01% |
23,630
| – | – |
|
309
Primis Financial Corp
FRST
$389M
| $1.81M | 0.01% |
214,781
-1,320
| -0.6% | -$11K |
|
|
TCN
310
DELISTED
Tricon Residential Inc.
TCN
| $1.76M | 0.01% |
200,310
-2,500
| -1% | -$20.4K |
|
311
Liberty Media Series A
FWONA
$21.9B
| $1.75M | 0.01% |
27,060
-209
| -0.8% | -$13.2K |
|
312
CME Group
CME
$91B
| $1.75M | 0.01% |
9,444
+35
| +0.4% | +$6.47K |
|
313
Dow Inc
DOW
$21.4B
| $1.72M | 0.01% |
32,209
-2,665
| -8% | -$142K |
|
314
Tesla
TSLA
$1.23T
| $1.71M | 0.01% |
6,535
+2
| +0% | +$400 |
|
315
General Motors
GM
$75.6B
| $1.71M | 0.01% |
44,283
-7,427
| -14% | -$257K |
|
316
Ares Management
ARES
$28.3B
| $1.69M | 0.01% |
17,545
+2,295
| +15% | +$198K |
|
317
Teledyne Technologies
TDY
$30.5B
| $1.67M | 0.01% |
4,073
| – | – |
|
318
TJX Companies
TJX
$171B
| $1.67M | 0.01% |
19,731
+538
| +3% | +$42.4K |
|
319
CMS Energy
CMS
$23.2B
| $1.67M | 0.01% |
28,449
| – | – |
|
320
Public Storage
PSA
$60.1B
| $1.65M | 0.01% |
5,660
-25
| -0.4% | -$7.29K |
|
321
Plexus
PLXS
$6.93B
| $1.64M | 0.01% |
16,700
-500
| -3% | -$45.8K |
|
322
Markel Group
MKL
$25B
| $1.63M | 0.01% |
1,179
| – | – |
|
323
Amphenol
APH
$191B
| $1.62M | 0.01% |
38,238
-14,200
| -27% | -$552K |
|
324
Cigna
CI
$76.5B
| $1.61M | 0.01% |
5,750
-51
| -0.9% | -$13.3K |
|
325
Cullen/Frost Bankers
CFR
$10.3B
| $1.61M | 0.01% |
14,949
-1,400
| -9% | -$146K |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.